3 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital

Page 1 of 3

In this article, we will be looking at the 3 medical stocks to buy according to Mitchell Blutt’s Consonance Capital. You can see our detailed analysis of these stocks and head directly to 8 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital.

3. United Therapeutics Corporation (NASDAQ:UTHR)

Stake Value of Consonance Capital Management: $29,134,000

Percentage of Consonance Capital Management’s 13F Portfolio: 15.94%

Number of Hedge Fund Holders: 52

United Therapeutics Corporation (NASDAQ:UTHR) operates as a biotechnology company that engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

United Therapeutics Corporation (NASDAQ:UTHR) has gained 18.40% over the past twelve months. Consonance Capital Management’s stake in United Therapeutics Corporation (NASDAQ:UTHR) at the end of the third quarter of 2021 was $29.13 million.

Out of the 867 hedge funds being tracked by Insider Monkey, United Therapeutics Corporation (NASDAQ:UTHR) was a part of 52 hedge fund portfolios by the end of the third quarter of 2021, up from 45 positions in the prior quarter. The total stakes of these funds in United Therapeutics Corporation (NASDAQ:UTHR) were in excess of $2.17 billion.

Page 1 of 3